hero image
Dr. Phyllis Billia - University Health Network. Toronto, ON, CANADA

Dr. Phyllis Billia

Scientist, Toronto General Research Institute | University Health Network

Toronto, ON, CANADA

Dr. Filio Billia is a member of the Division of Cardiology at the University Health Network.

Media

Publications:

Documents:

Photos:

Dr. Phyllis Billia Photo

Videos:

Audio/Podcasts:

Biography

Dr. Filio Billia is a member of the Division of Cardiology at the University health Network and a Scientist at the Toronto General Research Institute. She completed her medical and research training at the University of Toronto. Recently she completed a post-doctoral fellowship with the world-renowned Dr. Tak W. Mak at the Campbell Family Institute for Cancer Research. She currently is the co-Director of the Peter Munk Cardiovascular Biobank and Medical Director of the Mechanical Circulatory Assist Program. She has embarked in her own research career with funding from the Canadian Institutes of Health Research.

Industry Expertise (2)

Research

Medical/Dental Practice

Areas of Expertise (5)

Cardiology

Heart Disease and Stroke

Heart Transplantation

Heart Failure

Cardiac Regeneration

Accomplishments (1)

Young Investigator Award

2014

Education (2)

University of Toronto: M.D., Medicine 2011

University of Toronto: Ph.D., Cardiology 2007

Languages (2)

  • Greek
  • English

Media Appearances (4)

Cancer Research Opens Doors to New Heart Therapies

UHN News  

2013-09-03

Dr. Phyllis Billia and her team of researchers have shown that heart cell regeneration is possible – but that a heart cell’s ability to regenerate is s​uppressed by​ natural "roadblocks". It’s believed that if these roadblocks can be removed, heart cells would be able to regenerate and multiply, potentially repairing damage caused by an injury – like a heart attack – to the hear​t. “Something prevents heart muscle cells from regenerating,” said Dr. Billia. “So, when the heart’s cells are damaged, the effect is irreversible.”...

view more

Heart transplant saves Krystina’s life, but fight for survival was just beginning

The Hamilton Spectator  

2014-11-01

Henniker asked her physician, Dr. Filio (Phyllis) Billia, to hold her hand on the way to the operating room. Billia told her she would be OK...

view more

Krinos Taste of the Danforth 2014

PR Newswire  

2014-08-28

GreekTown has also donated to Dr. Phyllis Billia's cancer research at Toronto General and Toronto Western Hospitals. GreekTown naturally supports a number of Greek initiatives, including donating to University of Toronto's Greek studies program, the Greek Community, the Hellenic Canadian Federation of Ontario, Nefeli (theatre and dance), Greek Orthodox Community of Mississauga, and Hellenic Home for the Aged...

view more

Heart scientists discover protein that may be 1 cause of heart failure

EurekAlert  

2011-05-23

"Our research suggests that PINK1 is an important switch that sets off a cascade of events affecting heart cell metabolism," says Dr. Phyllis Billia, principal author, clinician‑scientist and heart failure specialist at the Peter Munk Cardiac Centre. "This could be one of the inciting events in the development of heart failure."...

view more

Articles (5)

Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function


Circulation Research

2014 Patients in intensive care units are disconnected from their natural environment. Synchrony between environmental diurnal rhythms and intracellular circadian rhythms is essential for normal organ biology; disruption causes pathology. Whether ...

view more


Transcatheter Aortic Valve Implantation and Left Ventricular Assist Device: A Word of Caution


The Annals of Thoracic Surgery

2014 Aortic valve disease in the setting of a left ventricular assist device presents unique challenges. We present the case of a patient who underwent transcatheter aortic valve implantation to replace a stenotic aortic valve to facilitate left ventricular assist device explantation...

view more


A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity


Circulation

2013 Cardiac consequences of obesity include inflammation, hypertrophy, and compromised energy metabolism. Glucagon-like peptide-1 is an incretin hormone capable of cytoprotective actions that reduces inflammation and endoplasmic reticulum stress in ...

view more


Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo


Proceedings of the National Academy of Sciences

2013 Oxidative stress is caused by an imbalance between the production of reactive oxygen species (ROS) and the ability of an organism to eliminate these toxic intermediates. Although the Parkinson-susceptibility gene, Parkinson protein 7/DJ-1 (DJ-1), has been ...

view more


Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD


Journal of Cardiac Surgery

2013 The HeartWare ventricular assist device (HVAD) is a new generation centrifugal flow VAD recently introduced in Canada. The objective of this study was to compare the HVAD device to the HeartMate II (HMII) axial flow device. Very few studies have compared ...

view more


 Your profile is not published.

Contact